Compression Therapy Market - Top Three Drivers and Forecasts from Technavio

Technavio has published a new report on the global compression therapy market from 2017-2021. (Graphic: Business Wire)

LONDON--()--Technavio analysts forecast the global compression therapy market to grow at a CAGR of close to 6% during the forecast period, according to their latest report.

The research study covers the present scenario and growth prospects of the global compression therapy market for 2017-2021. To calculate the market size, Technavio analysts consider revenue generated from sales of compression products such as compression bandages, compression pumps, compression stockings, and compression tapes.

Compression pumps are used to provide intensive compression therapy. Compression pumps can be classified into two types, lymphedema pumps or DVT pumps. Lymphedema pumps and DVT pumps are unique in that they treat the diseases distinctly different. Lymphedema and DVT sleeves are to be only used in conjunction with their corresponding pump to provide compression.

Request a sample report:

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Technavio healthcare and life sciences analysts highlight the following three factors that are contributing to the growth of the global compression therapy market:

Increasing surgical procedures

The increasing surgical procedures such as hip and knee replacements increase the risk of DVT, thereby fueling the need for compression therapy systems. Surgeries often result in long periods of immobility, increasing the chances of developing DVT due to reduced blood flow. It is reported that over a million Americans undergo joint replacement surgeries every year.

Sapna Jha, a lead cardiovascular and metabolic disorders research analyst at Technavio, says, “After the treatment of varicose veins with micro phlebectomy, light-assisted stab phlebectomy, and radiofrequency ablations, physicians may prescribe compression stockings that can relieve pain and swelling. With an increase in the number of surgical procedures, the chances of developing thromboembolic events, requiring treatment using compression therapy systems are growing.”

Growing adoption of sequential compression device systems

The emergence of sequential compression therapy systems is expected to have a positive impact on the market, owing to its use in several applications. Sequential calf compression and graduated compression stockings are increasingly being used for prophylaxis in neurosurgery for the prevention of PE and DVT. Further, intraoperative sequential compression device systems are recommended during prolonged laparoscopic surgery to counter altered venous blood return from the lower extremities and consequent cardiac depression caused by pneumoperitoneum.

With sequential compressions, such as the recovery edge therapy, each cycle continuously offloads the venous system during a 30-40 seconds’ sequence, thereby moving a substantial amount of blood and waste products,” adds Sapna.

Presence of large patient pool with venous disorders and diabetes

According to the CDC 2016 survey, more than 29 million individuals in the US are living with diabetes and 86 million individuals with pre-diabetes. The increasing incidence of diabetes increases the internal risk factors such as swelling of legs, ankles, and feet, which will lead to venous disorders. Such rising incidence rates of diabetes and other related chronic diseases, in turn, increases the patient pool, which drives the compression therapy market growth.

Top vendors:

  • 3M
  • BSN Medical
  • Getinge Group
  • Medtronic

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like in-vitro diagnostics, oncology, and vaccines. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770

Release Summary

Technavio analysts forecast the global compression therapy market to grow at a CAGR of close to 6% during the forecast period, according to their latest report.



Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770